Curley Joanne 4
4 · Vera Therapeutics, Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Curley Joanne
Chief Development Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-12-16$2.90/sh+1,429$4,140→ 28,250 total - Exercise/Conversion
Class A Common Stock
2022-12-16$2.90/sh+783$2,268→ 27,604 total - Sale
Class A Common Stock
2022-12-16$19.12/sh−1,429$27,323→ 26,821 total - Sale
Class A Common Stock
2022-12-16$20.17/sh−783$15,793→ 26,821 total - Exercise/Conversion
Stock Option (right to buy)
2022-12-16−2,212→ 35,801 totalExercise: $2.90Exp: 2030-12-15→ Class A Common Stock (2,212 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022.
- [F2]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.88 to $19.82, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.06 to $20.515, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter.